nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0992	0.242	CbGeAlD
Procainamide—SCN9A—nephron tubule—focal segmental glomerulosclerosis	0.0261	0.0638	CbGeAlD
Procainamide—DNMT1—cortex of kidney—focal segmental glomerulosclerosis	0.0219	0.0536	CbGeAlD
Procainamide—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.0214	0.0523	CbGeAlD
Procainamide—SCN4A—kidney—focal segmental glomerulosclerosis	0.0205	0.05	CbGeAlD
Procainamide—SCN10A—nephron tubule—focal segmental glomerulosclerosis	0.0199	0.0486	CbGeAlD
Procainamide—SLC22A2—kidney—focal segmental glomerulosclerosis	0.0188	0.0459	CbGeAlD
Procainamide—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.0183	0.0447	CbGeAlD
Procainamide—SCN2A—cortex of kidney—focal segmental glomerulosclerosis	0.0177	0.0431	CbGeAlD
Procainamide—SCN3A—kidney—focal segmental glomerulosclerosis	0.0159	0.0389	CbGeAlD
Procainamide—SLC22A4—nephron tubule—focal segmental glomerulosclerosis	0.0159	0.0388	CbGeAlD
Procainamide—SCN3A—cortex of kidney—focal segmental glomerulosclerosis	0.0155	0.0379	CbGeAlD
Procainamide—SLC22A4—kidney—focal segmental glomerulosclerosis	0.014	0.0341	CbGeAlD
Procainamide—SLC22A4—cortex of kidney—focal segmental glomerulosclerosis	0.0136	0.0332	CbGeAlD
Procainamide—SLC22A1—kidney—focal segmental glomerulosclerosis	0.0133	0.0324	CbGeAlD
Procainamide—SLC22A3—kidney—focal segmental glomerulosclerosis	0.0127	0.031	CbGeAlD
Procainamide—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.0105	0.0257	CbGeAlD
Procainamide—BCHE—nephron tubule—focal segmental glomerulosclerosis	0.0102	0.025	CbGeAlD
Procainamide—SLC22A5—kidney—focal segmental glomerulosclerosis	0.00924	0.0225	CbGeAlD
Procainamide—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.009	0.022	CbGeAlD
Procainamide—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.234	CcSEcCtD
Procainamide—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00596	0.0145	CbGeAlD
Procainamide—SCN9A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00351	0.00624	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00349	0.0062	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00339	0.00602	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00336	0.00597	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00335	0.00595	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00326	0.0058	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00323	0.00574	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00323	0.00573	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00323	0.00573	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00323	0.00573	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.0032	0.00569	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00319	0.00567	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00311	0.00553	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00311	0.00553	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.0031	0.0055	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00309	0.00548	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00308	0.00547	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00308	0.00547	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00302	0.00537	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00297	0.00527	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00297	0.00527	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00297	0.00527	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00297	0.00527	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00297	0.00527	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00296	0.00525	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00286	0.00508	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00286	0.00508	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00284	0.00504	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00282	0.00501	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.0028	0.00497	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00273	0.00484	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00273	0.00484	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00272	0.00483	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.0027	0.00479	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00263	0.00467	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00263	0.00467	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00259	0.0046	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00258	0.00459	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00251	0.00445	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00249	0.00443	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00247	0.00439	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.0024	0.00426	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00239	0.00425	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00237	0.00422	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00237	0.00422	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—NOS2—focal segmental glomerulosclerosis	0.00234	0.00416	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.0023	0.00409	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.0023	0.00409	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00229	0.00407	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00229	0.00407	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00229	0.00406	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00228	0.00405	CbGpPWpGaD
Procainamide—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00224	0.00398	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00222	0.00395	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00222	0.00395	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.0022	0.0039	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.0022	0.0039	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00219	0.00389	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00216	0.00383	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00212	0.00376	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00212	0.00376	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00209	0.00371	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—MMP2—focal segmental glomerulosclerosis	0.00201	0.00357	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00201	0.00357	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.00192	0.00341	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00185	0.00328	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00184	0.00327	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—focal segmental glomerulosclerosis	0.00179	0.00318	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00176	0.00313	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00176	0.00312	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.00171	0.00304	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00169	0.00301	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00169	0.00301	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00165	0.00293	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00163	0.0029	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00163	0.0029	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00161	0.00286	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00157	0.00278	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00156	0.00277	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00149	0.00265	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00147	0.00261	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00143	0.00255	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00135	0.00239	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.00129	0.00229	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00125	0.00222	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00124	0.00221	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00118	0.00209	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00116	0.00206	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00115	0.00204	CbGpPWpGaD
Procainamide—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0412	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00111	0.00197	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00111	0.00197	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00109	0.00194	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00109	0.00193	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00107	0.0019	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00107	0.00189	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00107	0.00189	CbGpPWpGaD
Procainamide—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0389	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00105	0.00187	CbGpPWpGaD
Procainamide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0381	CcSEcCtD
Procainamide—SCN3A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00104	0.00185	CbGpPWpGaD
Procainamide—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.038	CcSEcCtD
Procainamide—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0378	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00103	0.00182	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00103	0.00182	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.00101	0.0018	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00101	0.0018	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.001	0.00178	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.001	0.00178	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00099	0.00176	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000983	0.00175	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000965	0.00171	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000965	0.00171	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000961	0.00171	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00094	0.00167	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000937	0.00167	CbGpPWpGaD
Procainamide—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000926	0.0338	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000886	0.00157	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000848	0.00151	CbGpPWpGaD
Procainamide—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00084	0.0307	CcSEcCtD
Procainamide—SCN9A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000818	0.00145	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000802	0.00143	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000789	0.0014	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000783	0.00139	CbGpPWpGaD
Procainamide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.0285	CcSEcCtD
Procainamide—SCN9A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000777	0.00138	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000768	0.00136	CbGpPWpGaD
Procainamide—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000768	0.0281	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000764	0.00136	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000761	0.00135	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000761	0.00135	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000752	0.00134	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000752	0.00134	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000743	0.00132	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.00073	0.0013	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000725	0.00129	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000725	0.00129	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000722	0.00128	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000722	0.00128	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000716	0.00127	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000714	0.00127	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000714	0.00127	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000706	0.00125	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000688	0.00122	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000688	0.00122	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000678	0.0012	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000652	0.00116	CbGpPWpGaD
Procainamide—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.0238	CcSEcCtD
Procainamide—SCN11A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000651	0.00116	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000646	0.00115	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00063	0.00112	CbGpPWpGaD
Procainamide—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000629	0.023	CcSEcCtD
Procainamide—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.0218	CcSEcCtD
Procainamide—SCN8A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000595	0.00106	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00059	0.00105	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000584	0.00104	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000577	0.00103	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000571	0.00101	CbGpPWpGaD
Procainamide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.0207	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000559	0.000992	CbGpPWpGaD
Procainamide—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.0204	CcSEcCtD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000553	0.000982	CbGpPWpGaD
Procainamide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00055	0.0201	CcSEcCtD
Procainamide—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00055	0.000977	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000537	0.000953	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000537	0.000953	CbGpPWpGaD
Procainamide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000529	0.0193	CcSEcCtD
Procainamide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.019	CcSEcCtD
Procainamide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.019	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000517	0.000919	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000517	0.000919	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000515	0.000915	CbGpPWpGaD
Procainamide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.0188	CcSEcCtD
Procainamide—SCN5A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00051	0.000906	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000509	0.000905	CbGpPWpGaD
Procainamide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.0184	CcSEcCtD
Procainamide—CHRM2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000497	0.000882	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00049	0.00087	CbGpPWpGaD
Procainamide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.0178	CcSEcCtD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000487	0.000865	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000484	0.00086	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000481	0.000855	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000479	0.000851	CbGpPWpGaD
Procainamide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.0174	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.00046	0.000818	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000459	0.000815	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000454	0.000806	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.0166	CcSEcCtD
Procainamide—DNMT1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000448	0.000796	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000447	0.000793	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000442	0.000786	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000442	0.000786	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000437	0.000776	CbGpPWpGaD
Procainamide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000433	0.0158	CcSEcCtD
Procainamide—SCN10A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000426	0.000758	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000426	0.000758	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000421	0.000748	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000419	0.000744	CbGpPWpGaD
Procainamide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.015	CcSEcCtD
Procainamide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000407	0.0149	CcSEcCtD
Procainamide—SLC22A3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.0004	0.00071	CbGpPWpGaD
Procainamide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.0145	CcSEcCtD
Procainamide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000394	0.0144	CcSEcCtD
Procainamide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000394	0.0144	CcSEcCtD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000388	0.00069	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000387	0.000687	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000374	0.000664	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000368	0.000654	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000367	0.000652	CbGpPWpGaD
Procainamide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.0134	CcSEcCtD
Procainamide—CHRM2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000365	0.000648	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000364	0.000646	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000362	0.000643	CbGpPWpGaD
Procainamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.0131	CcSEcCtD
Procainamide—ACHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000357	0.000635	CbGpPWpGaD
Procainamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.0129	CcSEcCtD
Procainamide—CHRM2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000349	0.000621	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000345	0.000613	CbGpPWpGaD
Procainamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.0125	CcSEcCtD
Procainamide—CHRM2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000333	0.000592	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000331	0.000589	CbGpPWpGaD
Procainamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.012	CcSEcCtD
Procainamide—BCHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000323	0.000574	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000321	0.000571	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000319	0.000566	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000317	0.000563	CbGpPWpGaD
Procainamide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.0116	CcSEcCtD
Procainamide—ACHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000315	0.000559	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000307	0.000545	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.0003	0.000533	CbGpPWpGaD
Procainamide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000296	0.0108	CcSEcCtD
Procainamide—ACHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00029	0.000515	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000287	0.000509	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000285	0.000506	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000284	0.000504	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000281	0.000499	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000281	0.000499	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000279	0.000495	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000277	0.000492	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000268	0.000476	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000265	0.000471	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000259	0.000459	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000255	0.000453	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000253	0.000449	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000251	0.000445	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000243	0.000433	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000238	0.000423	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000237	0.000421	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000234	0.000415	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000231	0.00041	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000227	0.000403	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.000218	0.000387	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000216	0.000384	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000215	0.000382	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000198	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000197	0.00035	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000196	0.000348	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.000195	0.000346	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.000187	0.000331	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000182	0.000323	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000179	0.000319	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000174	0.000309	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.000166	0.000296	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000165	0.000292	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000162	0.000288	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000151	0.000267	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000149	0.000264	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000147	0.00026	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000143	0.000254	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000139	0.000246	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000129	0.000229	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000128	0.000227	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000128	0.000227	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000124	0.00022	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000119	0.000211	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000117	0.000208	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000114	0.000203	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000106	0.000189	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000106	0.000188	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.79e-05	0.000174	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	8.94e-05	0.000159	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.15e-05	0.000145	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	7.65e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.24e-05	0.000111	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	5.87e-05	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.14e-05	9.14e-05	CbGpPWpGaD
